The Future of Post-PFA Care: Improving Outcomes Through Continuous Monitoring and AI Insights - Powered by Zywie-The Future of Post-PFA Care: Improving Outcomes Through Continuous Monitoring and AI Insights

The Future of Post-PFA Care: Improving Outcomes Through Continuous Monitoring and AI Insights - Powered by Zywie

Video Transcription

Video Summary

The discussion focused on post-ablation monitoring in the era of pulsed field ablation (PFA), with an emphasis on how best to track atrial fibrillation (AF) recurrence, guide anticoagulation decisions, and incorporate wearables and AI. Participants agreed that traditional ECG-based monitoring remains the most reliable approach for clinical decisions, though optimal cadence varies. Common strategies included 6- and 12-month monitors, while research settings may benefit from more intensive monitoring such as ILRs or repeated 14-day monitors.<br /><br />Wearables like Apple Watch were viewed as promising but not yet fully ready for clinical workflow integration due to data overload, validation issues, reimbursement barriers, and limited infrastructure. AI was proposed as a possible solution to filter and interpret wearable data, personalize monitoring, and reduce clinician burden.<br /><br />PFA-specific issues included potentially shorter blanking periods, reduced early recurrences, and questions about long-term durability and complications such as coronary spasm or hemolysis. The group also discussed using monitoring for broader endpoints like quality of life, exercise capacity, heart rate variability, and stroke risk. Finally, there was strong interest in ongoing trials and consensus statements to help determine when anticoagulation can safely be stopped after ablation, especially in low-burden, low-risk patients.

Keywords

pulsed field ablation

atrial fibrillation recurrence

post-ablation monitoring

electrocardiogram monitoring

wearables

artificial intelligence

anticoagulation management

clinical trials